Transgenic <it>fat-1 </it>mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders

Transgenic <it>fat-1 </it>mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders

<p>Abstract</p> <p>Polyunsaturated fatty acids (PUFAs) form an important constituent of all the cell membranes in the body. PUFAs such as arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) form precursors to both pro-inflammatory and anti-inflammatory...

Full description

Bibliographic Details
Main Authors:	Puskás László G, Das Undurti N
Format:	Article
Language:	English
Published:	BMC 2009-12-01
Series:	Lipids in Health and Disease
Online Access:	http://www.lipidworld.com/content/8/1/61

Similar Items

Transgenic mouse models of childhood-onset psychiatric disorders
by: Robertson, Holly Rochelle, et al.
Published: (2014)

From Lab to Life: Exploring Cutting-Edge Models for Neurological and Psychiatric Disorders
by: Masaru Tanaka, et al.
Published: (2024-03-01)

Alzheimer's disease - neurological or psychiatric disorder?
by: Alina Poalelungi, et al.
Published: (2013-03-01)

Isoprenoid Pathway And Neurological And Psychiatric Disorders
by: Ravikumar A, et al.
Published: (1999-01-01)

Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders
by: Alexei Verkhratsky, et al.
Published: (2016-01-01)

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
by: Heeok Hong, et al.
Published: (2016-05-01)

Use of probiotics in treating psychiatric and neurological disorders
by: Saiyeda Maha Fatima, et al.
Published: (2023-12-01)

Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders
by: Shahin Akhondzadeh, et al.
Published: (2006-04-01)

Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders
by: Shahin Akhondzadeh, et al.
Published: (2006-03-01)

Editorial: Pathophysiologic Insights From Biomarker Studies in Neurological Disorders
by: Stefan Bittner, et al.
Published: (2020-02-01)

Integrative Lighting Aimed at Patients with Psychiatric and Neurological Disorders
by: Xinxi Zeng, et al.
Published: (2023-12-01)

Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders
by: Liangen Yu, et al.
Published: (2022-10-01)

Editorial: Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders
by: Enza Palazzo, et al.
Published: (2019-03-01)

Comparison of Prevalence of Neurological Soft Signs in Psychiatric Disorders
by: Seyyed Hadi Mo'tamedi, et al.
Published: (2002-06-01)

CK2—An Emerging Target for Neurological and Psychiatric Disorders
by: Julia Castello, et al.
Published: (2017-01-01)

Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice.
by: Soizic Lecocq, et al.
Published: (2018-01-01)

Linking activation of microglia and peripheral monocytic cells to the pathophysiology of psychiatric disorders
by: Yuta eTakahashi, et al.
Published: (2016-06-01)

Multiple Myeloma: More than One Pathophysiology to Induce Neurological Disorders
by: Mohamed Eltayieb Elawad, et al.
Published: (2020-01-01)

Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders
by: Xiuqi Chen, et al.
Published: (2021-05-01)

MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes
by: Das Undurti N, et al.
Published: (2011-09-01)

The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders
by: Michał Kosowski, et al.
Published: (2021-05-01)

The Use of lithium in psychiatric, viral and neurological disorders - a review
by: Barbara Denys, et al.
Published: (2023-07-01)

The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders
by: Maria Fernanda Naufel, et al.
Published: (2023-07-01)

Pineal gland: structural variants and their role in neurological and psychiatric disorders
by: Anastasia V. Shilova, et al.
Published: (2022-01-01)

Editorial: Integrity of the Autonomic Nervous System in Psychiatric and Neurological Disorders
by: Timo Siepmann, et al.
Published: (2020-02-01)

Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
by: Dan Li, et al.
Published: (2022-09-01)

Long-COVID, neurological and cardiovascular disorders
by: Oleksandr Saienko, et al.
Published: (2023-03-01)

Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders
by: Nicole Poladian, et al.
Published: (2023-07-01)

Ion Channels and Mental Illness: Exploring etiology and pathophysiology in major psychiatric disorders
by: Kathleen D. Askland
Published: (2015-04-01)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
by: Claudia Sagheddu, et al.
Published: (2021-10-01)

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
by: Kenji Hashimoto
Published: (2019-01-01)

Takotsubo Cardiomyopathy—Acute Cardiac Dysfunction Associated With Neurological and Psychiatric Disorders
by: Sylvia J. Buchmann, et al.
Published: (2019-08-01)

Hepatitis C virus infection, and neurological and psychiatric disorders – A review
by: Lydia Yarlott, et al.
Published: (2017-03-01)

5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders
by: Hridya Jayamohananan, et al.
Published: (2019-08-01)

Corrigendum: "Editorial: Neurological and psychiatric disorders in endocrine diseases"
by: Gianluca eTamagno, et al.
Published: (2015-06-01)

A transgenic mouse model of sickle cell disorder.
by: Greaves, D, et al.
Published: (1990)

Stress-related cellular pathophysiology as a crosstalk risk factor for neurocognitive and psychiatric disorders
by: Iryna S. Palamarchuk, et al.
Published: (2023-12-01)

EFFICACY OF GLUTEN-FREE DIET IN PATIENTS WITH NEUROLOGICAL DISEASES AND PSYCHIATRIC DISORDERS: MYTH OR REALITY?
by: Yu. A. Dmitrieva, et al.
Published: (2018-02-01)

The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders
by: Manish Kumar Tripathi, et al.
Published: (2020-07-01)

Protective effects of Ethanolic Extract of Emblica officinalis (amla) on Cardiovascular Pathophysiology of Rats, Fed with High Fat Diet
by: Pallavi Shantkumar Kanthe, et al.
Published: (2017-09-01)